RENBP and malignant colon neoplasm: The results showed that the targets of ursolic acid in treating colon cancer mainly included the TNF signaling pathway; the AGE-RAGE signaling pathway in diabetic complications, human cancer virus infections, hepatitis B, and Kaposi sarcoma-associated virus infections; and IL-17 signaling pathways.